Most sold healthcare stocks in Q2 2014

See which Healthcare stocks institutional investors trimmed or exited the most in Q2 2014, measured as net reductions in reported share positions from Q1 2014 into Q2 2014. Notable reductions at the top of this list include PFIZER INC (PFE), MERCK & CO. INC. (MRK), ELI LILLY & CO (LLY), ZOETIS INC (ZTS). These rankings are based on SEC 13F filings from the investors we track.

SymbolNameNet sharesNet valueNewAddedTrimmedSold outHolding now
PFEPFIZER INC-11,549,354-$6.23M045011
MRKMERCK & CO. INC.-3,885,859-$178.66K025012
LLYELI LILLY & CO-1,917,970-$99.30K00505
ZTSZOETIS INC-1,749,629-$42.79K00112
UHSUNIVERSAL HEALTH SERVICES-B-1,564,156-$110.88K00111
CAHCARDINAL HEALTH INC-1,535,782-$107.78K11022
TMOTHERMO FISHER SCIENTIFIC INC-1,351,231-$197.59K02609
BSXBOSTON SCIENTIFIC CORP-1,305,550-$51.71K00202
ILMNILLUMINA INC-1,238,519$54.72K00112
SYKSTRYKER CORP-1,146,743-$56.74K21306
DVADAVITA INC-1,062,744$85.85K03115
BKDBROOKDALE SENIOR LIVING INC-856,298-$29.12K00202
ABBVABBVIE INC-568,187-$15.78K10306
DGXQUEST DIAGNOSTICS INC-503,191-$28.47K01304
CRLCHARLES RIVER LABORATORIES-474,914-$45.14K01203
VRTXVERTEX PHARMACEUTICALS INC-388,561-$27.48K00020
DXCMDEXCOM INC-380,843-$15.75K00010
PBHPRESTIGE CONSUMER HEALTHCARE-335,548-$3.88K00101
WATWATERS CORP-313,904-$41.02K00212
CCRNCROSS COUNTRY HEALTHCARE INC-297,402-$2.75K00101
BIIBBIOGEN INC-259,433-$78.04K11013
RDYDR. REDDY'S LABORATORIES-ADR-230,400-$9.44K00101
PODDINSULET CORP-197,700-$10.67K00101
PFMTPERFORMANT FINANCIAL CORP-196,908-$1.63K00101
BRKRBRUKER CORP-191,100-$3.97K00101
ALGNALIGN TECHNOLOGY INC-186,632$19.12K11103
PCRXPACIRA BIOSCIENCES INC-171,500-$12.00K00010
ALNYALNYLAM PHARMACEUTICALS INC-158,700-$10.65K00010
AMNAMN HEALTHCARE SERVICES INC-157,000-$2.26K00101
EBSEMERGENT BIOSOLUTIONS INC-155,387-$5.63K00101
RVTYREVVITY INC-151,200-$6.51K00101
OMIOWENS & MINOR INC-150,573-$5.63K00101
CHECHEMED CORP-148,437-$8.48K02204
HUMHUMANA INC-146,900-$16.56K00010
LFCRLIFECORE BIOMEDICAL INC-142,471$1.66K00202
PETSPETMED EXPRESS INC-121,801-$1.51K00101
FOLDAMICUS THERAPEUTICS INC-121,000-$25000010
ABTABBOTT LABORATORIES-114,158$73.73K324012
PACBPACIFIC BIOSCIENCES OF CALIF-105,766-$56600010
SEMSELECT MEDICAL HOLDINGS CORP-93,048-$82200101
FONRFONAR CORP-91,375-$3.15K00101
BCRXBIOCRYST PHARMACEUTICALS INC-90,514-$95800010
ICUIICU MEDICAL INC-86,701-$4.59K00101
UTMDUTAH MEDICAL PRODUCTS INC-81,249-$7.20K01102
MTDMETTLER-TOLEDO INTERNATIONAL-80,154-$18.17K00101
ANIKANIKA THERAPEUTICS INC-75,000-$1.16K00101
HAEHAEMONETICS CORP/MASS-63,826-$1.50K00121
ICADICAD INC-59,200-$1.35K00101
MMSIMERIT MEDICAL SYSTEMS INC-57,003-$67100101
TFXTELEFLEX INC-56,095-$9.91K01304
20 symbols with net change in reported shares from tracked managers.−12.7M−9.5M−6.4M−3.2M0.00Net change in reported shares (tracked managers)PFEMRKLLYZTSUHSCAHTMOBSXILMNSYKDVABKDABBVDGXCRLVRTXDXCMPBHWATCCRNSymbol

Frequently asked questions about Most sold healthcare stocks in Q2 2014

  • What are the most sold Healthcare stocks in Q2 2014?

    The most sold healthcare stocks in Q2 2014 are those with the largest decrease in reported share counts across tracked institutional investors compared to Q1 2014, based on SEC 13F filings.

  • Which healthcare stocks did institutional investors trimmed or exited the most in Q2 2014?

    Among the managers we track, net reductions were largest in companies such as PFIZER INC (PFE), MERCK & CO. INC. (MRK), ELI LILLY & CO (LLY), based on aggregated 13F data.

  • How is institutional selling calculated?

    Selling is calculated by summing the net decrease in shares reported by tracked investors between two consecutive quarterly 13F snapshots (compared to Q1 2014).

  • Does this include all institutional owners?

    These rankings are based on a subset of tracked institutional investors who file SEC 13F reports. While not exhaustive, the dataset includes many of the largest and most influential funds.

  • Are these trades real-time?

    No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.